| Visits/time points | |||||
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
Procedures | Screening | Baseline | Follow-up | |||
 | Maximum 42 days | Week 0 | Week 4 | Week 12 | Week 24 | Week 28 |
Informed consent | x | Â | Â | Â | Â | Â |
Inclusion/exclusion | x | x | x | x | x | Â |
Demographics | x | Â | Â | Â | Â | Â |
Medical history | x | Â | Â | Â | Â | Â |
Concomitant medication | x | x | x | x | x | Â |
Hand pain 0–10 NRS | x | x | x | x | x |  |
Pain manikin | Â | x | Â | x | x | Â |
Physical examination | x | Â | x | x | x | Â |
Vital signs | x | Â | x | x | x | Â |
Blood screening | x | Â | Â | Â | Â | Â |
Urine dipstick | x | Xa | Xa | Xa | Xa | Â |
Urine pregnancy test | Xa | Xa | Xa | Xa | Xa | Â |
Bilateral hand X-ray (if applicable) | x | Â | Â | Â | Â | Â |
Hand pain rating (remote) | Training | x | x | x | x | Â |
Randomisation | Â | x | Â | Â | Â | Â |
Prescription/dispensing | Â | x | Â | x | Â | Â |
Reported study medication compliance | Â | Â | x | x | x | Â |
Advice on barrier contraception | Â | Xa | Xa | Xa | Xa | Â |
Joint count | Â | x | Â | x | x | Â |
Questionnaires | Â | x | Â | x | x | Â |
Photographs of swollen hand joints | Â | x | Â | x | x | Â |
Grip strength | Â | x | Â | x | x | Â |
Safety blood monitoring c | Â | Â | x | x | x | Â |
Safety/adverse events | Â | Â | x | x | x | x |
Advice on weaning off study medication | Â | Â | Â | Â | x | Â |
Bang’s Blinding Index |  |  |  |  | x |  |
End of treatment questionnaire | Â | Â | Â | Â | x | Â |
Focus groupb (optional) | Â |